Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double-blind study of afamelanotide implant in patients undergoing porfimer sodium photodynamic therapy
2008-002446-39Phase 2Completed
- Sponsor
- Clinuvel Pharmaceuticals
- Start
- Aug 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Barrett's esophagus comparing Afamelanotide implant arm with Placebo implant arm (2 arms). Primary endpoint: Reduction in duration of phototoxicity after PDT. Started Aug 2008; status: completed.
02
Drugs
Afamelanotide
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on 2008-002446-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002446-39.